In summary, our study suggests that elevated KAL levels contribute to the occurrence and development of NAFLD by targeting the CGI-58/NF-κB/TNFα pathway (Fig. 9). The gene discussed is SERPINA4; the disease is metabolic dysfunction-associated steatotic liver disease.